NYSE:HUM - Humana Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$306.07 -1.25 (-0.41 %)
(As of 12/11/2018 04:00 PM ET)
Previous Close$307.32
Today's Range$303.60 - $313.02
52-Week Range$242.00 - $355.88
Volume873,000 shs
Average Volume789,117 shs
Market Capitalization$41.98 billion
P/E Ratio26.14
Dividend Yield0.46%
Beta0.99
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. The company operates through four segments: Retail; Group and Specialty; Healthcare Services; and Individual Commercial. The Retail segment offers Medicare and supplemental benefit plans to individuals or through group accounts. This segment also has contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. The Group and Specialty segment provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health and voluntary insurance benefits; financial protection products; and administrative services only products to individuals and employer groups. It also offers military services, such as TRICARE South Region contract. The Healthcare Services segment provides pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. The Individual Commercial segment offers individual commercial fully-insured medical health insurance benefits under the HumanaOne brand. The company also provides closed-block long-term care insurance policies. As of December 31, 2017, it had approximately 14 million members in medical benefit plans, as well as approximately 7 million members in specialty products. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.

Receive HUM News and Ratings via Email

Sign-up to receive the latest news and ratings for HUM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSE
Industry Hospital & medical service plans
Sub-IndustryManaged Health Care
SectorMedical
Current SymbolNYSE:HUM
Previous Symbol
CUSIP44485910
Phone502-580-1000

Debt

Debt-to-Equity Ratio0.45
Current Ratio1.68
Quick Ratio1.68

Price-To-Earnings

Trailing P/E Ratio26.14
Forward P/E Ratio21.21
P/E Growth1.45

Sales & Book Value

Annual Sales$53.77 billion
Price / Sales0.78
Cash Flow$15.3342 per share
Price / Cash Flow19.96
Book Value$68.89 per share
Price / Book4.44

Profitability

EPS (Most Recent Fiscal Year)$11.71
Net Income$2.45 billion
Net Margins2.70%
Return on Equity19.10%
Return on Assets6.36%

Miscellaneous

Employees45,900
Outstanding Shares137,190,000
Market Cap$41.98 billion
OptionableOptionable

Humana (NYSE:HUM) Frequently Asked Questions

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana announced a quarterly dividend on Friday, November 2nd. Shareholders of record on Monday, December 31st will be given a dividend of $0.50 per share on Friday, January 25th. This represents a $2.00 annualized dividend and a yield of 0.65%. The ex-dividend date is Friday, December 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its board has initiated a share repurchase plan on Friday, December 15th 2017, which permits the company to buyback $3,000,000,000.00 in shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Shares buyback plans are often a sign that the company's management believes its shares are undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) posted its quarterly earnings data on Wednesday, November, 7th. The insurance provider reported $4.58 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.29 by $0.29. The insurance provider had revenue of $14.21 billion for the quarter, compared to analysts' expectations of $13.97 billion. Humana had a net margin of 2.70% and a return on equity of 19.10%. During the same quarter in the previous year, the firm posted $3.39 earnings per share. View Humana's Earnings History.

When is Humana's next earnings date?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, February 6th 2019. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY18 earnings guidance on Wednesday, November, 28th. The company provided earnings per share (EPS) guidance of $14.40 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $14.43.

What price target have analysts set for HUM?

18 Wall Street analysts have issued 1 year price objectives for Humana's stock. Their predictions range from $250.00 to $418.00. On average, they expect Humana's share price to reach $349.7778 in the next year. This suggests a possible upside of 14.3% from the stock's current price. View Analyst Price Targets for Humana.

What is the consensus analysts' recommendation for Humana?

18 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Humana in the last year. There are currently 6 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Humana.

Has Humana been receiving favorable news coverage?

Headlines about HUM stock have trended somewhat positive this week, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Humana earned a news sentiment score of 1.1 on InfoTrie's scale. They also assigned media headlines about the insurance provider a news buzz of 10.0 out of 10, meaning that recent media coverage is extremely likely to have an effect on the stock's share price in the next few days.

Are investors shorting Humana?

Humana saw a increase in short interest in the month of November. As of November 30th, there was short interest totalling 3,549,873 shares, an increase of 63.6% from the November 15th total of 2,170,421 shares. Based on an average trading volume of 1,124,142 shares, the days-to-cover ratio is currently 3.2 days. Approximately 2.6% of the shares of the stock are short sold. View Humana's Current Options Chain.

Who are some of Humana's key competitors?

Who are Humana's key executives?

Humana's management team includes the folowing people:
  • Mr. Bruce Dale Broussard, Pres, CEO & Director (Age 56)
  • Mr. Brian Andrew Kane, Sr. VP & CFO (Age 45)
  • Mr. Christopher Mark Todoroff, Chief Legal Officer (Age 55)
  • Mr. Timothy S. Huval, Chief HR Officer (Age 52)
  • Ms. Jody L. Bilney, Chief Consumer Officer (Age 57)

Who are Humana's major shareholders?

Humana's stock is owned by many different of retail and institutional investors. Top institutional shareholders include FMR LLC (8.99%), BlackRock Inc. (8.94%), Vanguard Group Inc. (7.37%), Capital International Investors (5.99%), Capital Research Global Investors (2.86%) and Capital World Investors (2.45%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, David A Jr/Ky Jones, Elizabeth D Bierbower, Heidi S Margulis, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Institutional Ownership Trends for Humana.

Which institutional investors are selling Humana stock?

HUM stock was sold by a variety of institutional investors in the last quarter, including Capital World Investors, MERIAN GLOBAL INVESTORS UK Ltd, Wells Fargo & Company MN, Mitsubishi UFJ Trust & Banking Corp, Alliancebernstein L.P., AQR Capital Management LLC, Point72 Asset Management L.P. and Ceredex Value Advisors LLC. Company insiders that have sold Humana company stock in the last year include Brian P Leclaire, Bruce D Broussard, Christopher H Hunter, Cynthia H Zipperle, Elizabeth D Bierbower, Heidi S Margulis, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge, Timothy Alan Wheatley, Timothy S Huval and William Kevin Fleming. View Insider Buying and Selling for Humana.

Which institutional investors are buying Humana stock?

HUM stock was acquired by a variety of institutional investors in the last quarter, including Capital International Investors, Renaissance Technologies LLC, Ffcm LLC, Morgan Stanley, FMR LLC, Marshall Wace North America L.P., Vanguard Group Inc. and BlackRock Inc.. View Insider Buying and Selling for Humana.

How do I buy shares of Humana?

Shares of HUM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Humana's stock price today?

One share of HUM stock can currently be purchased for approximately $306.07.

How big of a company is Humana?

Humana has a market capitalization of $41.98 billion and generates $53.77 billion in revenue each year. The insurance provider earns $2.45 billion in net income (profit) each year or $11.71 on an earnings per share basis. Humana employs 45,900 workers across the globe.

What is Humana's official website?

The official website for Humana is http://www.humana.com.

How can I contact Humana?

Humana's mailing address is 500 West Main Street, LOUISVILLE KY, 40202. The insurance provider can be reached via phone at 502-580-1000.


MarketBeat Community Rating for Humana (NYSE HUM)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  684 (Vote Outperform)
Underperform Votes:  746 (Vote Underperform)
Total Votes:  1,430
MarketBeat's community ratings are surveys of what our community members think about Humana and other stocks. Vote "Outperform" if you believe HUM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HUM will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/11/2018 by MarketBeat.com Staff

Featured Article: Debt-To-Equity Ratio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel